Details for Patent: 5,576,353

Title:	Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
Abstract:	R(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.
Inventor(s):	Youdim; Moussa B. H. (Haifa, IL), Finberg; John P. M. (Tivon, IL), Levy; Ruth (Tel-Aviv, IL), Yellin; Haim (Ramat-Gan, IL)
Assignee:	Teva Pharmaceutical Industries Ltd. (Jerusalem, IL) Technion Research and Development Foundation, Ltd. (Haifa, IL)
Filing Date:	Jun 02, 1995
Application Number:	08/459,402
Claims:	1. A method of treating a subject for memory disorders which comprises administering to the subject an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof effective to treat the subject. 2. The method of claim 1, wherein the R(+)-N-propargyl-1-aminoindan or pharmaceutically acceptable salt thereof is administered orally or rectally. 3. The method of claim 2, wherein the amount administered is 2 to 20 mg per daily dosage unit. 4. The method of claim 3, wherein the amount administered is 5 to 10 mg per daily dosage unit. 5. The method of claim 1, wherein the R(+)-N-propargyl-1-aminoindan or pharmaceutically acceptable salt thereof is administered parenterally. 6. The method of claim 5, wherein the amount administered is 1 to 10 mg per mL per daily dosage unit. 7. The method of claim 6, wherein the amount administered is 2 to 5 mg per mL per daily dosage unit.